Not Signed In - Phase II Data Shows Ovation's Novel Compound Clobazam To Be Well Tolerated In Patients With Catastrophic Epilepsy
Tue, 05 Dec 2006 08:00 AM EST
... Results from the first study in the United States designed to evaluate the safety and efficacy of clobazam as adjunctive therapy in patients with Lennox-Gastaut syndrome (LGS), one of the most severe forms of childhood epilepsy, demonstrated that clobazam is well tolerated. [click link for full article] ...
Related Topics
- Epilepsy
- Data & Statistics
- Data Analysis
- National Data
- Aspirin and Carisoprodol
- Mining
- Clinical Trials
- Nystatin and Triamcinolone
- Food Recommendations: South Beach Diet - Phase 1
- Food Recommendations: South Beach Diet - Phase 2
- Seizures (in about half of patients)
- Vaccinations For HIV/AIDs Patients
- What Your Female Patients Want to Know About Bladder Control
- Smoking Cessation and Continued Risk in Cancer Patients
- Approximately one-half of patients with small tumors will get back useful hearing in the affected ear after surgery.
- Logging
- Chemical Safety
- Kniest dysplasia
- Aspirin, Butalbital, Caffeine and Codeine
- Visualization
email this page
print this page
bookmark this page
feedback on this page
